Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Peritoneal Diseases 1Ovarian Neoplasms 1Ovarian Diseases 1Neoplasms 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Fallopian Tube Diseases 1Carcinoma, Non-Small-Cell Lung 1Basal Cell Carcinoma of the Head and Neck 1

Interventions

Carboplatin 87Paclitaxel 77Bevacizumab 38Topotecan 23liposomal doxorubicin 22Gemcitabine 22Taxes 21Cisplatin 17Drug Therapy 14Docetaxel 14Cyclophosphamide 14pembrolizumab 13Immunoglobulin G 12Disulfides 12veliparib 8rucaparib 8mirvetuximab soravtansine 8niraparib 7Albumin-Bound Paclitaxel 7sargramostim 6Filgrastim 6Erlotinib Hydrochloride 6Doxorubicin 6pazopanib 5Granulocyte-Macrophage Colony-Stimulating Factor 5Chemotherapy, Adjuvant 5CP protocol 5trebananib 4temsirolimus 4olaparib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Fallopian Tube Neoplasms × Tissue Banks × Clear all
NCT02973750 2023-01-26

Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer

H. Lee Moffitt Cancer Center and Research Institute

Completed
20 enrolled
Gynecologic

Fallopian Tube Diseases, Fallopian Tube Neoplasms, Neoplasms, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡